Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Cross validation of the factor structure of the 20-item Toronto Alexithymia Scale: An Italian multicenter study
1996553 citationsC. Bressi, Graeme J. Taylor et al.Journal of Psychosomatic Researchprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of F Giberti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Giberti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Giberti more than expected).
This network shows the impact of papers produced by F Giberti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Giberti. The network helps show where F Giberti may publish in the future.
Co-authorship network of co-authors of F Giberti
This figure shows the co-authorship network connecting the top 25 collaborators of F Giberti.
A scholar is included among the top collaborators of F Giberti based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with F Giberti. F Giberti is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
18 of 18 papers shown
1.
Giberti, F, et al.. (2016). Casi Clinici. PSICOTERAPIA E SCIENZE UMANE. 751–770.1 indexed citations
2.
Giberti, F, et al.. (2003). [Results of reserpine therapy in psychiatry].. PubMed. 7(1). 29–42.
3.
Giberti, F & Lucilla Gregoretti. (2003). [First trials of psychopharmacological antagonism; experimental psychoses induced with d-lysergic acid diethylamide and treated with chlorpromazine and reserpine].. PubMed. 7(4). 301–10.1 indexed citations
4.
Loeb, C & F Giberti. (2000). [Clinical & electroencephalographic aspects of psychotic syndromes in epileptics].. PubMed. 9(4). 219–29.
5.
Giberti, F, et al.. (2000). [Comparative study of the psychopathological effects of lysergic acid ethylamide, (L. A. E. 32) & lysergic acid diethylamide, (L. S. D. 25) in neurotics].. PubMed. 10(2). 97–110.1 indexed citations
6.
Giberti, F, et al.. (1998). [Study of the neurologic and psychopathologic effects of a new drug with psychotomimetic action (JB-329 or Ditran) in depressed patients].. PubMed. 13. 167–75.
7.
Bressi, C., Graeme J. Taylor, James D. A. Parker, et al.. (1996). Cross validation of the factor structure of the 20-item Toronto Alexithymia Scale: An Italian multicenter study. Journal of Psychosomatic Research. 41(6). 551–559.553 indexed citations breakdown →
8.
Giberti, F, et al.. (1996). [IMIPRAMINE AND ELECTROSHOCK IN THE THERAPY OF DEPRESSIONS: CLINICO-STATISTICAL ANALYSIS OF THE RESULTS IN 437 CASES].. PubMed. 16. 29–42.1 indexed citations
Giberti, F, et al.. (1961). [Contribution to the study of hystericism during intravenous administration of sympathomimetic amines (Weckanalysis)].. PubMed. 85. 170–84.1 indexed citations
Fazio, Carolina, et al.. (1958). [A new drug (iminodibenzylic derivative, G 22355) in therapy of depressive states].. PubMed. 49(65-66). 3143–8.7 indexed citations
15.
Giberti, F, et al.. (1957). [Further results of new therapy of Parkinsonian syndromes; therapeutic action of 3-phenyl-3-b-diethylamino-ethyl-2-6-dioxy-piperidine hydrochloride administered alone and with reserpine and ritalin].. PubMed. 116(9). 404–7.1 indexed citations
16.
Giberti, F, et al.. (1956). [First results of a new treatment of Parkinson's disease and of parkinsonism; therapeutic effect of 3-phenyl-3-(beta-diethylamino-ethyl)-2, 6-dioxo piperidine alone and with reserpine and ritalin; preliminary note].. PubMed. 115(3). 71–4.1 indexed citations
17.
Giberti, F & Lucilla Gregoretti. (1954). [Sexual content and symbolism in the Rorschach test in psychiatry].. PubMed. 6(6). 396–408.2 indexed citations
18.
Giberti, F. (1954). [Clinical and therapeutic considerations on a case of mental anorexia].. PubMed. 82(1). 69–76.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.